ACI submits tox data to FSA
The Association for the Cannabinoid Industry (ACI) submitted a complete toxicological package to the Food Standards Agency (FSA) on Friday, 4 November 2022, to support members’ novel food applications. These applications account for 33% of the applications made to the FSA, and align to approximately half of the products identified on the public list. Currently […]
What rules and regulations govern CBD in the UK?
A high-level overview of the regulatory framework governing the three most common categories of CBD products. Those operating in the consumer arena or the CBD wholesale market should be advised of the web of regulatory tools which lay out the basis for compliant cannabinoids in the UK. CBD is widely available off the shelf via […]
Back on track: Swiss ingredients manufacturer Linnea reinstated on FSA’s CBD list
Linnea, the expert manufacturer of botanical extracts for the pharmaceutical industry, has had its novel foods application reinstated by the Food Standards Agency, following its removal from the list earlier this year. Cannabinoid Insight understands the company was originally told its application had been validated, only for the FSA to later rule Linnea out due […]
The UK’s CBD list is here. What happens next?
The long awaited list of ingestible CBD products permitted for sale was published on 31 March 2022. A total of 3,536 products linked to 70 applications have been given the green light to remain on the market by the Food Standards Agency, however the majority are awaiting the outcome of further evidence. This means making […]
Review of UK public policy and regulatory stewardship of the legal cannabis industry announced
The Centre for Medicinal Cannabis, the Association for the Cannabinoid Industry and the First November Group have today announced the launch the Hodges Review – a new, wide ranging commission to assess regulation and public policy relating to the UK’s legal cannabis industry. The review will be led by Professor Christopher Hodges, Emeritus Professor of […]
CBD: coming to a TV screen near you
This week, UK-based CBD company, British Cannabis celebrates the launch of a television advert campaign for its premium flagship range of supplements and cosmetics, CBD by BRITISH CANNABIS™ The campaign comes as part of a £500,000 investment from British Cannabis towards increased brand awareness and a consumer recruitment campaign for 2022/23. The advert, produced by […]
FSA provides update on the status of the public list, white labelling and looming deadline
The Food Standards Agency (FSA) has said the public list of approved CBD products will be updated ‘as and when applications have been validated.’ The FSA will release a list in bulk form in the interim, indicating the applications which are ‘awaiting evidence’. A spokesperson for the food safety body met with the Association for […]
Everything you need to know about CBD vapes
Updated 30.08.2022 Vaping has enjoyed a rise in popularity in the UK in recent years. There are now an estimated 4.3 million British adults who vape, with many taking up the habit as a means to quit smoking. New data from Action on Smoking and Health (ASH), suggests 8.3% of adults in England, Wales and Scotland vape […]
UK CBD sector on standby for release of FSA’s list of permitted products
The UK’s consumer health sector is set for its biggest shake-up in more than a decade when the Food Standards Agency (FSA) releases its eagerly-awaited public list of CBD products permitted for sale to consumers. Only products on the list will be able to stay on the market, while those not included will have to […]
FSA issues clarification and new deadline for toxicology data
A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products. Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]